Biovelocita
Our team provides a hands-on, robust framework for startups, combining direct management, financial backing and access to Sofinnova’s extensive infrastructure and network.
We partner with Europe's leading medical research organizations to identify ground-breaking science.
"Working with researchers to create new start-ups is personally very rewarding, because you're helping to move promising science into the real world, where patients benefit."
"Scaling up early-stage companies from academic concepts to industrial development provides a great sense of accomplishment."
"The hands-on approach to building companies really appeals to the scientist in me. And we are translating discoveries in the laboratory into novel medicines."
"We expect to build an exciting portfolio of leading biotechnology companies from cutting-edge European science."
The
Team
Gabriella Camboni
Partner, Sofinnova Partners - Biovelocita Strategy
Matthieu Coutet
Partner, Sofinnova Partners - Biovelocita Strategy
Alex Leech
Partner, Sofinnova Partners - Biovelocita Strategy
Zhizhong Joel Yao
Partner, Sofinnova Partners - Biovelocita Strategy
Marie Duranteau
Associate, Program Manager, Sofinnova Partners - Biovelocita Strategy
Cristina Pelizon
Senior Associate, Program Manager, Sofinnova Partners - Biovelocita Strategy
Companies
Related News
Invivo Partners joins Sofinnova Partners in Signadori Bio
Forth Tx launches with backing from Sofinnova Partners to revolutionize fibrosis treatments
BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership